Here, gene expression profiles of NSCLC patients treated with anti-PD-1 therapy in GSE126044 and SKCM patients treated with ICI therapy obtained from CRI iAltas were used to evaluate whether TMERSscore could be used as a marker to assess the efficacy of ICI treatment. Here, PDCD1 is linked to non-small cell lung carcinoma.